๐Ÿซ€
AI Methodologist
Your 24/7 methodology advisor
๐Ÿ›ก๏ธ
Secure Critique
Encrypted methodology review with open source agents

Join researchers already using Aqrab

Free during beta
โ†“

Why Researchers Choose Aqrab

Built on the standards your reviewers actually use.

47
Methodology Standards
CONSORTSTROBEPROBASTPRISMASPIRITARRIVEMOOSESTARDTRIPODRECORD
16
AI Agents
TGF-ฮฒMAPK/ERKNotchWntNF-ฮบBHedgehog
๐Ÿ”ฌ
Methodology Critique at Scale

Automated detection of selection bias, confounding, information bias, and attrition โ€” across every dimension of your study design. 100x faster than manual review.

๐Ÿ“š
PubMed Integration

Auto-fetch any published paper by PMID. Aqrab pulls the abstract, metadata, and full MeSH terms โ€” then critiques the methodology in under a minute.

๐Ÿ“Š
5-Dimension Scoring

Every critique scores five axes: study design ยท outcome measurement ยท confounding control ยท sample size ยท clinical relevance. One number, five stories.

Aqrab vs Manual Review

Not another chatbot. A structured methodology engine.

FeatureAqrab ๐Ÿฆ‚Peer ReviewerChatGPT
Speed< 60 secondsDaysโ€“weeks~30 seconds
Bias detectionโœ“ Structured~ Variableโœ— Informal
Checklist complianceโœ“ 47 standards~ Inconsistentโœ— None
Reproducibilityโœ“ Identical runsโœ— Inter-rater variationโœ— Stochastic
Costโœ“ Fixed pricingโœ— $200โ€“800/reviewโœ“ Low
Citation-linkedโœ“ Every critique~ Sometimesโœ— Hallucinations

How Aqrab Protects Your Research

Built for clinical research environments where privacy is non-negotiable.

๐Ÿšซ
Zero Training Guarantee

Your data never trains our models. Not now, not ever.

๐Ÿ”’
Encrypted at Rest

Study designs encrypted with AES-256 and stored in isolated vaults.

๐Ÿ”
Open Source Agents

Inspect every critique decision. Full transparency, no black boxes.

๐Ÿฅ
HIPAA Ready

Built for clinical research compliance from day one.

Recent Critiques

Real trials. Real scores. See what Aqrab catches.

RECITE4.1/5
Romiplostim for CIT ยท NEJM 2026

Well-designed RCT with transparent adverse event reporting. Minor thromboembolic signal flagged appropriately.

MAPLE-HCM3.7/5
Aficamten vs Metoprolol ยท NEJM 2025

Comparator arm deteriorated โ€” metoprolol impairment inflates the apparent treatment effect.

TEMPO-13.4/5
Tavapadon for Parkinson's ยท Lancet Neurology 2025

Functional unblinding from 33% dropout rate. Side effects revealed allocation to participants.

TRACE3.3/5
Transradial vs Transfemoral ยท Stroke 2026

Failed non-inferiority. Operator experience confounded results across sites.

INDUCE-33.2/5
Feladilimab for HNSCC ยท Lancet Oncology 2025

Adaptive 2-in-1 design caught its own failure โ€” but the design itself complicates causal interpretation.

Pricing

Start free. Scale when you're ready.

Free
$0
  • โœ“3 critiques / month
  • โœ“Core methodology check
  • โœ“CONSORT + STROBE standards
  • โœ“Basic rigor score
Start free
Most popular
Pro
$99/mo
  • โœ“Unlimited critiques
  • โœ“All 16 AI agents
  • โœ“47 methodology standards
  • โœ“PubMed integration
  • โœ“Citation-linked feedback
  • โœ“PDF export
Start Pro
Institutional
$500/mo
  • โœ“Everything in Pro
  • โœ“Team workspace
  • โœ“Priority support
  • โœ“API access
  • โœ“Custom agent configuration
  • โœ“Audit logs
Contact us
Limited spots
Founding Researcher
$500 one-time
  • โœ“Lifetime Pro access
  • โœ“Founding badge on profile
  • โœ“Early access to new agents
  • โœ“Direct feedback channel
  • โœ“Price locked forever
Claim lifetime

Frequently Asked Questions

Everything you need to know before your first critique.

What methodology standards does Aqrab check against?+
How is this different from asking ChatGPT?+
Can I critique my own unpublished work?+
What does the rigor score mean?+
Is my study data private?+
Do you offer academic discounts?+